The clinical and genetic characterization of a large Indian congenital myasthenic syndrome cohort by hotspot screening, followed by whole-exome sequencing in 156 genetically diagnosed patients from 141 families, identified MACF1 as a novel candidate gene whose mutation is responsible for causing the neuromuscular junction defects of the disease [47]. This evidence concerns the gene MACF1 and congenital myasthenic syndrome.